Recent MIRM News
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/11/2024 12:45:00 AM
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 08/28/2024 08:01:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/09/2024 11:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:11:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:00 PM
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/07/2024 08:01:00 PM
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024 • Business Wire • 07/31/2024 08:30:00 PM
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older • Business Wire • 07/25/2024 12:30:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/10/2024 11:00:00 PM
- Approbation du LIVMARLI de Mirum Pharmaceuticals dans l'Union européenne pour les patients atteints de PFIC • Business Wire • 07/08/2024 08:46:00 PM
- LIVMARLI von Mirum Pharmaceuticals wird in der Europäischen Union für Patienten mit PFIC zugelassen • Business Wire • 07/08/2024 08:20:00 PM
- Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC • Business Wire • 07/08/2024 12:30:00 PM
- Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX • Business Wire • 06/28/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:03:33 PM
- Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies • Business Wire • 06/17/2024 12:00:00 PM
- Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024 • Business Wire • 06/16/2024 09:00:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/11/2024 02:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 10:23:47 PM
- Langfristige Daten aus den LIVMARLI-Studien von Mirum bei ALGS und PFIC auf dem EASL-Kongress vorgestellt • Business Wire • 06/07/2024 04:04:00 AM
- Les données à long terme des études LIVMARLI de Mirum sur l’ALGS et la PFIC présentées au congrès de l’EASL • Business Wire • 06/07/2024 04:04:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:38:26 PM
- Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress • Business Wire • 06/06/2024 01:30:00 PM
- Mirum Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/05/2024 08:05:00 PM
- Mirum Pharmaceuticals: positive CHMP-Stellungnahme für LIVMARLI® (Maralixibat) als orale Lösung zur Behandlung von PFIC bei Patienten ab einem Alter von drei Monaten • Business Wire • 05/31/2024 09:02:00 PM
- Mirum Pharmaceuticals annonce un avis favorable du CHMP pour la solution orale LIVMARLI® (maralixibat) dans le traitement des patients atteints de CIFP âgés de trois mois et plus • Business Wire • 05/31/2024 05:12:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM